Table 1.
Comparison of clinical characteristics according to BMI categories
|
BMI |
≤21 kg/m2 N = 11 |
21-25 kg/m2 N = 52 |
>25 kg/m2 N = 108 |
P-value |
|---|---|---|---|---|
| Clinical characteristics | ||||
| Age, years |
74 (10) |
70 (11) |
67 (10) |
0.04¶ |
| Sex, female % |
46 |
37 |
20 |
0.04† |
| eGFR, ml/min/m2 |
77 (31) |
66 (29) |
74 (31) |
0.27¶ |
| CHF Duration*, months |
1.5 (1–69) |
3 (2–30) |
6 (3–36) |
0.17† |
| LVEF, % |
34 (8) |
30 (9) |
30 (8) |
0.35¶ |
| NYHA class I/II, % |
82 |
73 |
73 |
0.81† |
| Type 2 Diabetes Mellitus, % |
9 |
15 |
33 |
0.02† |
| P-sodium, mmol/l | 138 (3) | 137 (4) | 138 (3) | 0.35¶ |
P-value is a comparison of mean (¶ = ANOVA)/ median/percentages († = Kruskal Wallis Test/Chi2 Test) between patients with BMI ≤ 21, 21–25 and BMI >25 kg/m2.
Mean (SD), * = median (interquartile range); ¶ = ANOVA; † = Pearson chi2 test/Kruskal Wallis Test.
Abbreviations: BMI: body mass index, CHF: chronic heart failure, eGFR: estimated glomerular filtration rate, LVEF: left ventricular ejection fraction.